- Home
- GTES vs IONS Comparison
GTES vs IONS Comparison
Compare GTES & IONS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTES
- IONS
- Stock Information
- Founded
- GTES 1911
- IONS 1989
- Country
- GTES United States
- IONS United States
- Employees
- GTES N/A
- IONS N/A
- Industry
- GTES Industrial Machinery/Components
- IONS Biotechnology: Pharmaceutical Preparations
- Sector
- GTES Industrials
- IONS Health Care
- Exchange
- GTES Nasdaq
- IONS Nasdaq
- Market Cap
- GTES 5.6B
- IONS 6.0B
- IPO Year
- GTES 2018
- IONS 1991
- Fundamental
- Price
- GTES $20.38
- IONS $32.69
- Analyst Decision
- GTES Buy
- IONS Buy
- Analyst Count
- GTES 10
- IONS 18
- Target Price
- GTES $22.50
- IONS $62.00
- AVG Volume (30 Days)
- GTES 2.2M
- IONS 1.5M
- Earning Date
- GTES 02-06-2025
- IONS 02-19-2025
- Dividend Yield
- GTES N/A
- IONS N/A
- EPS Growth
- GTES N/A
- IONS N/A
- EPS
- GTES 0.83
- IONS N/A
- Revenue
- GTES $3,442,100,000.00
- IONS $803,067,000.00
- Revenue This Year
- GTES N/A
- IONS N/A
- Revenue Next Year
- GTES $3.48
- IONS $10.85
- P/E Ratio
- GTES $24.59
- IONS N/A
- Revenue Growth
- GTES N/A
- IONS 30.57
- 52 Week Low
- GTES $12.41
- IONS $32.80
- 52 Week High
- GTES $23.34
- IONS $53.17
- Technical
- Relative Strength Index (RSI)
- GTES 44.30
- IONS 36.31
- Support Level
- GTES $19.48
- IONS $33.92
- Resistance Level
- GTES $21.14
- IONS $35.45
- Average True Range (ATR)
- GTES 0.43
- IONS 1.22
- MACD
- GTES -0.07
- IONS -0.19
- Stochastic Oscillator
- GTES 54.22
- IONS 1.84
About GTES Gates Industrial Corporation plc
Gates Industrial Corp PLC is a manufacturer of engineered power transmission and fluid power solutions. The company has two operating segments; Power Transmission and Fluid Power segments. The Power Transmission solutions convey power and control motion. It is used in applications in which belts, chains, cables, geared transmissions, or direct drives transfer power from an engine or motor to another part or system. The Fluid power solutions are used in applications in which hoses and rigid tubing assemblies either transfer power hydraulically or convey fluids, gases, or granular materials from one location to another. The company generates key revenue from the Power Transmission segment.
About IONS Ionis Pharmaceuticals Inc.
Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. Its broad clinical and preclinical pipeline targets a wide variety of diseases, with an emphasis on cardiovascular, metabolic, neurological, and rare diseases. Ionis and partner Biogen brought Spinraza to market in 2016 as a treatment for a rare neuromuscular disorder, spinal muscular atrophy, and Biogen launched ALS drug Qalsody in 2023. Ionis brought two additional drugs to market via its cardiovascular-focused subsidiary Akcea, including ATTR amyloidosis drug Tegsedi (2018) and cardiology drug Waylivra (Europe, 2019). Ionis and AstraZeneca launched polyneuropathy drug Wainua in 2024.